Video

Dr. Hussain on the Importance of Multidisciplinary Care

Maha H. Hussain, MBChB, from the University of Michigan Comprehensive Cancer Center, explains that care should be multi- and interdisciplinary, in order to provide the best possible outcomes.

Maha H. Hussain, MBChB, a professor of Medicine and Urology at the University of Michigan and the associate director for Clinical Research at the University of Michigan Comprehensive Cancer Center, explains that care should be multi- and interdisciplinary, in order to provide the best possible outcomes.

The goal of patient care should not be focused on the physician who sees the patient but rather on providing the best possible treatment, Hussain states. In general, men diagnosed with hormone-sensitive prostate cancer are seen by urologists. However, in the context of clinical trials, the monitoring of experimental treatments, logistics, and chemotherapy might be better handled by an oncologist, Hussain believes.

Ultimately, care that is provided by a team that includes an oncologist, urologist, radiologist, and other specialties is the best option. How this is balanced, should be a secondary consideration. However, a patient should not be deprived of seeing a second physician, Hussain adds.

Related Videos
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Tracy George, MD
Elias Jabbour, MD
Bently P. Doonan, MD
Eytan M. Stein, MD
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center
Aditya Bardia, MD, MPH, FASCO, professor, Department of Medicine, Division of Hematology/Oncology, director, Translational Research Integration, UCLA Health Jonsson Comprehensive Cancer Center